Induction of virus-specific cytotoxic T lymphocytes by in vivo electric administration of peptides (Q45738396)

15 December 2017

title

Induction of virus-specific cytotoxic T lymphocytes by in vivo electric administration of peptides (English)

1 reference

15 December 2017

Uno-Furuta S

1

1 reference

15 December 2017

Tamaki S

2

1 reference

15 December 2017

Takebe Y

3

1 reference

15 December 2017

Takamura S

4

1 reference

15 December 2017

Kamei A

5

1 reference

15 December 2017

Kim G

6

1 reference

15 December 2017

Kuromatsu I

7

1 reference

15 December 2017

Kaito M

8

1 reference

15 December 2017

Adachi Y

9

1 reference

15 December 2017

Yasutomi Y

10

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

15 December 2017

1 reference

15 December 2017

volume

19

1 reference

15 December 2017

issue

15-16

1 reference

15 December 2017

page(s)

2190-2196

1 reference

Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Introduction of soluble protein into the class I pathway of antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Cells process exogenous proteins for recognition by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Peptide-induced antiviral protection by cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated Peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Vaccines to prevent viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

A single immunization with a plasmid encoding hepatitis C virus (HCV) structural proteins under the elongation factor 1-alpha promoter elicits HCV-specific cytotoxic T-lymphocytes (CTL).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

The influence of DNA sequence on the immunostimulatory properties of plasmid DNA vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

B70 antigen is a second ligand for CTLA-4 and CD28.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Genetically modified tumour vaccines--where we are today.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

CD4-independent in vivo priming of murine CTL by optimal MHC class I-restricted peptides derived from intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp 120.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Liposome-mediated delivery stimulates a class I-restricted cytotoxic T cell response to soluble antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Direct gene transfer into rat liver cells by in vivo electroporation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Determination of Optimal Parameters for in Vivo Gene Transfer by Electroporation, Using a Rapid in Vivo Test for Cell Permeabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

The B7 and CD28 receptor families

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Gene-modified tumor cells as cellular vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900336-4

7 January 2021

10.1016/S0264-410X(00)00336-4

Identifiers

DOI

1 reference

15 December 2017

1 reference